First Time Loading...

Stratec SE
XETRA:SBS

Watchlist Manager
Stratec SE Logo
Stratec SE
XETRA:SBS
Watchlist
Price: 41.55 EUR -0.24%
Updated: Apr 29, 2024
Section:
 

Relative Value

The Relative Value of one SBS stock under the Base Case scenario is 81.15 EUR. Compared to the current market price of 41.55 EUR, Stratec SE is Undervalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SBS Relative Value
Base Case
81.15 EUR
Undervaluation 49%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.9
P/S
P/S
Price to Sales
1.9
vs History
95
vs Industry
51
Median 3Y
3.7
Median 5Y
3.7
Industry
2.4
Forward
1.8
More Details
38.7
P/E
P/E
Price to Earnings
38.7
vs History
58
vs Industry
13
Median 3Y
37
Median 5Y
40.2
Industry
23.2
Forward
22.2
More Details
26.1
P/OCF
P/OCF
Price to OCF
26.1
vs History
68
vs Industry
15
Median 3Y
25.9
Median 5Y
32.3
Industry
15.5
More Details
11
P/FCFE
P/FCFE
Price to FCFE
11
vs History
76
vs Industry
33
Median 3Y
65.5
Median 5Y
67.4
Industry
23.5
More Details
2.2
P/B
P/B
Price to Book Value
2.2
vs History
95
vs Industry
40
Median 3Y
4.8
Median 5Y
5.1
Industry
2.2
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
96
vs Industry
47
Median 3Y
4
Median 5Y
4
Industry
2.5
Forward
2
More Details
8.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.8
vs History
96
vs Industry
26
Median 3Y
13.3
Median 5Y
15.2
Industry
5.2
More Details
13.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.1
vs History
96
vs Industry
26
Median 3Y
18.7
Median 5Y
20.1
Industry
12.5
Forward
11.3
More Details
22.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.1
vs History
96
vs Industry
21
Median 3Y
27.2
Median 5Y
32.1
Industry
17.2
Forward
18.9
More Details
29.3
EV/OCF
EV/OCF
Enterprise Value to OCF
29.3
vs History
66
vs Industry
14
Median 3Y
28.4
Median 5Y
33.7
Industry
15.1
More Details
284.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
284.3
vs History
9
vs Industry
1
Median 3Y
39.6
Median 5Y
27.3
Industry
19.7
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
95
vs Industry
49
Median 3Y
3.1
Median 5Y
3.2
Industry
2
More Details

Multiples Across Competitors

SBS Competitors Multiples
Stratec SE Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Stratec SE
XETRA:SBS
506.3m EUR 1.9 38.7 13.1 22.1
US
Abbott Laboratories
NYSE:ABT
186.5B USD 4.6 33.1 19.5 29
US
Intuitive Surgical Inc
NASDAQ:ISRG
133.1B USD 18.2 67 54.9 68.9
US
Stryker Corp
NYSE:SYK
127.6B USD 6.2 40.3 25.1 31.1
US
Boston Scientific Corp
NYSE:BSX
107.2B USD 7.5 68.3 31.7 47.3
IE
Medtronic PLC
NYSE:MDT
106B USD 3.3 25.2 13.5 19.1
US
Becton Dickinson and Co
NYSE:BDX
66.9B USD 3.4 54.9 18.4 38.9
DE
Siemens Healthineers AG
XETRA:SHL
59.1B EUR 2.7 38.9 18.6 31.4
US
Edwards Lifesciences Corp
NYSE:EW
52B USD 8.7 37 26.8 29
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
366.6B CNY 10.6 32.2 28.1 28.1
US
Dexcom Inc
NASDAQ:DXCM
47.9B USD 13.2 88.5 59.6 77.6

See Also

Summary
SBS intrinsic value, competitors valuation, and company profile.
DCF Valuation
SBS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SBS stock valuation using valuation multiples.
Wall Street Estimates
SBS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SBS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.